BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 19339810)

  • 1. Fundus autofluorescence before and after photodynamic therapy for chronic central serous chorioretinopathy.
    Ozmert E; Batioğlu F
    Ophthalmologica; 2009; 223(4):263-8. PubMed ID: 19339810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Photodynamic therapy in the treatment of chronic central serous chorioretinopathy.
    Valmaggia C; Niederberger H
    Klin Monbl Augenheilkd; 2006 May; 223(5):372-5. PubMed ID: 16705507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphologic changes in acute central serous chorioretinopathy evaluated by fourier-domain optical coherence tomography.
    Fujimoto H; Gomi F; Wakabayashi T; Sawa M; Tsujikawa M; Tano Y
    Ophthalmology; 2008 Sep; 115(9):1494-500, 1500.e1-2. PubMed ID: 18394706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early laser photocoagulation treatment as an option in central serous chorioretinopathy.
    Sturm V
    Ophthalmic Surg Lasers Imaging; 2009; 40(5):453-60. PubMed ID: 19772268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundus autofluorescence in acute and chronic-recurrent central serous chorioretinopathy.
    Framme C; Walter A; Gabler B; Roider J; Sachs HG; Gabel VP
    Acta Ophthalmol Scand; 2005 Apr; 83(2):161-7. PubMed ID: 15799726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central serous chorioretinopathy.
    Marcuson J; Riley T
    Optometry; 2008 May; 79(5):241-51. PubMed ID: 18436164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Optical coherence tomography features of central exudative chorioretinopathy].
    He SZ; Wang W; Li XL; Tang R
    Zhonghua Yan Ke Za Zhi; 2003 Nov; 39(11):669-72. PubMed ID: 14766062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fundus autofluorescence and central serous chorioretinopathy.
    Spaide RF; Klancnik JM
    Ophthalmology; 2005 May; 112(5):825-33. PubMed ID: 15878062
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of central serous chorioretinopathy by optical coherence tomography and multifocal electroretinography.
    Moschos M; Brouzas D; Koutsandrea C; Stefanos B; Loukianou H; Papantonis F; Moschos M
    Ophthalmologica; 2007; 221(5):292-8. PubMed ID: 17728550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of retinal angiomatous proliferation by photodynamic therapy.
    Gómez-Ulla F; Abraldes MJ; Fernández M; Olmedo M
    Optom Vis Sci; 2006 Aug; 83(8):546-9. PubMed ID: 16909080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Photodynamic Therapy on Optical Coherence Tomography Angiography in Eyes with Chronic Central Serous Chorioretinopathy.
    Xu Y; Su Y; Li L; Qi H; Zheng H; Chen C
    Ophthalmologica; 2017; 237(3):167-172. PubMed ID: 28171871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Photodynamic therapy in retinal angiomatous proliferations].
    Kürzinger GR; Lang GK; Lang GE
    Klin Monbl Augenheilkd; 2008 Feb; 225(2):159-64. PubMed ID: 18293269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posterior cystoid retinal degeneration in central serous chorioretinopathy.
    Piccolino FC; De La Longrais RR; Manea M; Cicinelli S
    Retina; 2008; 28(7):1008-12. PubMed ID: 18698305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared and short-wavelength autofluorescence imaging in central serous chorioretinopathy.
    Ayata A; Tatlipinar S; Kar T; Unal M; Ersanli D; Bilge AH
    Br J Ophthalmol; 2009 Jan; 93(1):79-82. PubMed ID: 18829635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of central serous chorioretinopathy (CSCR).
    Kanyange ML; De Laey JJ
    Bull Soc Belge Ophtalmol; 2002; (284):39-44. PubMed ID: 12161989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natural history of pigment epithelial detachment associated with central serous chorioretinopathy.
    Mudvari SS; Goff MJ; Fu AD; McDonald HR; Johnson RN; Ai E; Jumper JM
    Retina; 2007; 27(9):1168-73. PubMed ID: 18046220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular photodynamic therapy in choroidal neovascularization complicating idiopathic central serous chorioretinopathy.
    Canakis C; Conway MD; Livir-Rallatos C; Naaman GJ; Ratnakaram R; Men G; Peyman GA
    Ophthalmic Surg Lasers Imaging; 2004; 35(2):168-71. PubMed ID: 15088832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy for chronic central serous chorioretinopathy.
    Cardillo Piccolino F; Eandi CM; Ventre L; Rigault de la Longrais RC; Grignolo FM
    Retina; 2003 Dec; 23(6):752-63. PubMed ID: 14707823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety enhanced photodynamic therapy for chronic central serous chorioretinopathy: one-year results of a prospective study.
    Chan WM; Lai TY; Lai RY; Tang EW; Liu DT; Lam DS
    Retina; 2008 Jan; 28(1):85-93. PubMed ID: 18185143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors related to photodynamic therapy for central serous chorioretinopathy.
    Moon JW; Yu HG; Kim TW; Kim HC; Chung H
    Graefes Arch Clin Exp Ophthalmol; 2009 Oct; 247(10):1315-23. PubMed ID: 19421764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.